Basophil granule proteins
US5476839A · kind A · utility
10Cited by
2References
4Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 19, 1994 |
| Grant date | Dec 19, 1995 |
| Priority date | — |
| Expiry date | May 19, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/838
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Several natural polypeptides (basophil granule proteins, "BGP") derived from the cytoplasmic granules of human basophils, and modified forms thereof, are described. These polypeptides, the DNA which encodes them and antibodies which recognize them, are useful as diagnostics for, and treatments for, pathologies involving inflammatory and IgE-mediated responses, parasitic and helminthic infections, hypersensitivity reactions and certain types of leukocytic leukemias.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.